We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

1 hedge funds and large institutions have $235K invested in Sio Gene Therapies Inc. Common Stock in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCA
Private Capital Advisors
Connecticut
+$235K

Top Sellers

No sellers this quarter

SIOX Hedge Fund Activity: Q2 2026 in Review

1 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q2 2026, worth a combined $235K.

Buyers outnumbered sellers: 1 fund opened new SIOX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Private Capital Advisors, opening a new position worth an estimated $235K.

  • 1 institutional investor held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q2 2026, up from 0 in Q1 2026.
  • Funds reported $235K of Sio Gene Therapies Inc. Common Stock stock for Q2 2026.
  • 1 fund opened new Sio Gene Therapies Inc. Common Stock positions in Q2 2026 and 0 closed out, a net change of +1 holder.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q2 2026 was Private Capital Advisors, an estimated $235K added.

Based on aggregated 13F filings for Q2 2026.